logo
    Enhancement and Inhibition of Drug Metabolism
    Annual Review of Pharmacology (1971)
    M. W. Anders
    134
    Citation
    0
    Reference
    10
    Related Paper
    Citation Trend
    Abstract:
    Due to the massive data sets available for drug candidates, modern drug discovery has advanced to the big data era. Central to this shift is the development of artificial intelligence approaches to implementing innovative modeling based on the dynamic, ...Read More
    Keywords:
    Drug Development
    Topics:
    Computational Drug Discovery Methods
    Drug-induced hepatotoxicity-from viewpoint of drug metabolism
    Rinsho Kagaku/Rinsho kagaku (2009)
    Toshihiko Ikeda
    Citations (0)
    Assessment of Pharmacokinetic Drug–Drug Interactions in Humans: In Vivo Probe Substrates for Drug Metabolism and Drug Transport Revisited
    The Annual Review of Pharmacology and Toxicology (2018)
    Uwe FuhrChih‐hsuan HsinXia LiWafaâ JabraneFritz Sörgel
    Pharmacokinetic parameters of selective probe substrates are used to quantify the activity of an individual pharmacokinetic process (PKP) and the effect of perpetrator drugs thereon in clinical drug-drug interaction (DDI) studies. For instance, oral caffeine is used to quantify hepatic CYP1A2 activity, and oral dagibatran etexilate for intestinal P-glycoprotein (P-gp) activity. However, no probe substrate depends exclusively on the PKP it is meant to quantify. Lack of selectivity for a given enzyme/transporter and expression of the respective enzyme/transporter at several sites in the human body are the main challenges. Thus, a detailed understanding of the role of individual PKPs for the pharmacokinetics of any probe substrate is essential to allocate the effect of a perpetrator drug to a specific PKP; this is a prerequisite for reliably informed pharmacokinetic models that will allow for the quantitative prediction of perpetrator effects on therapeutic drugs, also in respective patient populations not included in DDI studies.
    Drug-drug interaction
    Citations (41)
    [Symposium--drug metabolism and drug action. 7. Species differences in drug metabolism].
    PubMed (1970)
    Hiroshi KitagawaTetsuya Kamataki
    Drug action
    Citations (0)
    Drug Disposition and Drug–Drug Interactions: Importance of First-Pass Metabolism in Gut and Liver
    Springer eBooks (2009)
    Catherine K. YeungPing ZhaoDanny D. ShenKenneth E. Thummel
    Biotransformation
    Citations (2)
    Effect of cold exposure on drug action and hepatic drug metabolism in the rat
    Toxicology and Applied Pharmacology (1972)
    George C. FullerWilliam F. BousquetTom S. Miya
    Drug action
    Mechanism of Action
    Citations (16)
    [Symposium--drug metabolism and drug action. 2. Inhibition and induction of drug metabolizing enzyme activities in the liver microsomes in relation to drug effects].
    PubMed (1970)
    Ryuji Kato
    Drug action
    Liver enzyme
    Citations (0)
    Pharmacological and toxicological aspects of drug metabolism
    Springer eBooks (1986)
    G. Gordon GibsonPaul Skett
    Drug action
    Biotransformation
    Mechanism of Action
    Citations (7)
    Pharmacological and toxicological aspects of drug metabolism
    Springer eBooks (1996)
    G. Gordon GibsonPaul Skett
    Drug action
    Biotransformation
    Mechanism of Action
    Citations (1)
    Using ’Humanized’ TK-NOG mice to predict human drug metabolism and drug-drug interactions
    Drug Metabolism Reviews (2011)
    Taisei NomuraYingqian ChenMing ZhengFitch WlGary Peltz
    Drug-drug interaction
    Citations (0)
    [Symposium--drug metabolism and drug action. 5. Sex difference in drug effects and drug metabolizing enzyme activity in the rat liver microsomes--normal and chemically and physiologically altered states].
    PubMed (1970)
    Yoshihiro TochinoMatsubaratHaruto Takase
    Drug action
    Citations (0)